Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia

Eur J Clin Microbiol Infect Dis. 2007 Nov;26(11):843-5. doi: 10.1007/s10096-007-0366-5.

Abstract

A neutropenic patient with acute myeloid leukaemia experienced a breakthrough infection of Trichosporon asahii during posaconazole treatment. After treatment was changed to a combination therapy with voriconazole and liposomal amphotericin B, the infection resolved. Posaconazole works effectively as an antifungal prophylaxis and salvage therapy in rare invasive fungal infections. This case however illustrates that breakthrough infections with T. asahii may occur during posaconazole treatment.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Cross Infection / drug therapy
  • Cross Infection / microbiology*
  • Drug Therapy, Combination
  • Humans
  • Leukemia, Myeloid, Acute / complications*
  • Male
  • Mycoses / drug therapy
  • Mycoses / microbiology*
  • Pyrimidines / therapeutic use
  • Triazoles / therapeutic use*
  • Trichosporon / drug effects*
  • Trichosporon / isolation & purification*
  • Voriconazole

Substances

  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • liposomal amphotericin B
  • posaconazole
  • Amphotericin B
  • Voriconazole